Myocardial Infarction
| Name | Preis | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RFP Expressing Human Adipose Tissue-Derived Mesenchymal Stem Cells | Anmelden | RFP Expressing Human Adipose Tissue-Derived Mesenchymal Stem Cells | ||||||||||||||||
|
||||||||||||||||||
| Human Umbilical Cord-Derived Mesenchymal Stem Cells | Anmelden | Human Umbilical Cord-Derived Mesenchymal Stem Cells | ||||||||||||||||
|
||||||||||||||||||
| RFP Expressing Human Umbilical Cord-Derived Mesenchymal Stem Cells | Anmelden | RFP Expressing Human Umbilical Cord-Derived Mesenchymal Stem Cells | ||||||||||||||||
|
||||||||||||||||||
| Conditionally Immortalized Human Bone Marrow-Derived Mesenchymal Stem Cells | Anmelden | Conditionally Immortalized Human Bone Marrow-Derived Mesenchymal Stem Cells | ||||||||||||||||
|
||||||||||||||||||
| Conditionally Immortalized Human Adipose Tissue-Derived Mesenchymal Stem Cells | Anmelden | Conditionally Immortalized Human Adipose Tissue-Derived Mesenchymal Stem Cells | ||||||||||||||||
|
||||||||||||||||||
| Conditionally Immortalized Human Umbilical Cord-Derived Mesenchymal Stem Cells | Anmelden | Conditionally Immortalized Human Umbilical Cord-Derived Mesenchymal Stem Cells | ||||||||||||||||
|
||||||||||||||||||
| Human Induced Pluripotent Stem Cells | Anmelden | Human Induced Pluripotent Stem Cells | ||||||||||||||||
|
||||||||||||||||||
| Human Induced Pluripotent Stem Cells | Anmelden | Human Induced Pluripotent Stem Cells | ||||||||||||||||
|
||||||||||||||||||
| GFP Expressing Human Induced Pluripotent Stem Cells | Anmelden | GFP Expressing Human Induced Pluripotent Stem Cells | ||||||||||||||||
|
||||||||||||||||||
| RFP-Expressing Human Induced Pluripotent Stem Cells | Anmelden | RFP-Expressing Human Induced Pluripotent Stem Cells | ||||||||||||||||
|
||||||||||||||||||
| Human Induced Pluripotent Stem Cells | Anmelden | Human Induced Pluripotent Stem Cells | ||||||||||||||||
|
||||||||||||||||||
| CGP 20712 A | Anmelden | CGP 20712 A | ||||||||||||||||
|
||||||||||||||||||
| L-161982 | Anmelden | L-161982 | ||||||||||||||||
|
||||||||||||||||||
| T-Type calcium channel inhibitor(TTA-P2) | Anmelden | T-Type calcium channel inhibitor(TTA-P2) | ||||||||||||||||
|
||||||||||||||||||
| VPS34 inhibitor 1 (Compound 19, PIK-III analogue) | Anmelden | VPS34 inhibitor 1 (Compound 19, PIK-III analogue) | ||||||||||||||||
|
||||||||||||||||||
| VPS34 inhibitor 1 (Compound 19, PIK-III analogue) | Anmelden | VPS34 inhibitor 1 (Compound 19, PIK-III analogue) | ||||||||||||||||
|
||||||||||||||||||
| VPS34 inhibitor 1 (Compound 19, PIK-III analogue) | Anmelden | VPS34 inhibitor 1 (Compound 19, PIK-III analogue) | ||||||||||||||||
|
||||||||||||||||||
| VPS34 inhibitor(Compound 80) | Anmelden | VPS34 inhibitor(Compound 80) | ||||||||||||||||
|
||||||||||||||||||
| VPS34 inhibitor(Compound 80) | Anmelden | VPS34 inhibitor(Compound 80) | ||||||||||||||||
|
||||||||||||||||||
| VPS34 inhibitor(Compound 80) | Anmelden | VPS34 inhibitor(Compound 80) | ||||||||||||||||
|
||||||||||||||||||
| Dodecanoylcarnitine | Anmelden | Dodecanoylcarnitine | ||||||||||||||||
|
||||||||||||||||||
| Dodecanoylcarnitine | Anmelden | Dodecanoylcarnitine | ||||||||||||||||
|
||||||||||||||||||
| Dodecanoylcarnitine | Anmelden | Dodecanoylcarnitine | ||||||||||||||||
|
||||||||||||||||||
| Angiotensin II 5-valine | Anmelden | Angiotensin II 5-valine | ||||||||||||||||
|
||||||||||||||||||
| Cardiogenol C hydrochloride | Anmelden | Cardiogenol C hydrochloride | ||||||||||||||||
|
||||||||||||||||||


